(a) A substance shall be placed in schedule IA if it is found under AS 11.71.120 (c) to have the highest degree of danger or probable danger to a person or the public.
(b) Schedule IA includes, unless specifically excepted or listed in another schedule, any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:
(1) opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone, and their respective salts, but including the following:
(A) raw opium;
(B) opium extracts;
(C) opium fluid extracts;
(D) powdered opium;
(E) granulated opium;
(F) tincture of opium;
(G) codeine;
(H) ethylmorphine;
(I) etorphine hydrochloride;
(J) hydrocodone;
(K) hydromorphone;
(L) metopon;
(M) morphine;
(N) oxycodone;
(O) oxymorphone;
(P) thebaine;
(2) any salt, compound, derivative, or preparation of a substance included in (b)(1) of this section which is chemically equivalent or identical to any of the substances referred to in (b)(1) of this section; however, these substances do not include the isoquinoline alkaloids of opium;
(3) opium poppy and poppy straw;
(4) concentrate of poppy straw which is the crude extract of poppy straw in either liquid, solid, or powder form which contains the phennanthrine alkaloids of the opium poppy;
(5) [Repealed, Sec. 4 ch 57 SLA 2012].
(c) Schedule IA includes, unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan excepted:
(1) acetylmethadol;
(2) allylprodine;
(3) alphacetylmethadol;
(4) alphameprodine;
(5) alphamethadol;
(6) alphaprodine;
(7) anileridine;
(8) benzethidine;
(9) betacetylmethadol;
(10) betameprodine;
(11) betamethadol;
(12) betaprodine;
(13) bezitramide;
(14) clonitazene;
(15) dextromoramide;
(16) diampromide;
(17) diethylthiambutene;
(18) difenoxin;
(19) dihydrocodeine;
(20) dimenoxadol;
(21) dimepheptanol;
(22) dimethylthiambutene;
(23) dioxaphetyl butyrate;
(24) diphenoxylate;
(25) dipipanone;
(26) ethylmethythiamutene;
(27) etonitazene;
(28) etoxeridine;
(29) fentanyl;
(30) furethidine;
(31) hydroxpethidine;
(32) isomethadone;
(33) ketobemidone;
(34) levomethorphan;
(35) levomoramide;
(36) levorphanol;
(37) levophenacylmorphan;
(38) meperidine, also known as pethidine;
(39) metazocine;
(40) methadone;
(41) methadone-intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
(42) moramide-intermediate, 2-methyl-3-morpholino-1, 1-diphenyl- propane-carboxylic acid;
(43) morpheridine;
(44) noracymethadol;
(45) norlevorphanol;
(46) normethadone;
(47) norpipanone;
(48) pethidine, also known as merperidine;
(49) pethidine-intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
(50) pethidine-intermediate-B, ethyl-4-phenylpiperidine-4-carbox-ylate;
(51) pethidine-intermediate-C, 1-methyl-4-phenylpiperidine- 4-carboxylic acid;
(52) phenadoxone;
(53) phenampromide;
(54) phenazocine;
(55) phenomorphan;
(56) phenoperidine;
(57) piminodine;
(58) piritramide;
(59) propheptazine;
(60) properidine;
(61) propiram;
(62) racemethorphan;
(63) racemoramide;
(64) racemorphan;
(65) trimeperidine;
(66) alfentanil;
(67) alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)- ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4(N-propanilido) piperidine);
(68) bulk dextropropoxyphene (non-dosage form);
(69) carfentanil;
(70) sufentanil;
(71) tilidine;
(72) para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide);
(73) 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropana mide);
(74) acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenetnyl)-4-piperidinyl]-N-phenylacetamide );
(75) alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl) ethyl-4-piperidinyl]-N-phenylpropanamide);
(76) beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropan amide);
(77) beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phe nylpropanamide);
(78) 3-methylthiofentanyl (N-[(3-methyl-l-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpro panamide);
(79) thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide);
(80) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
(81) PEPAP (1-(-2-pheynethyl)-4-phenyl-4-acetoxypiperidine).
(d) Schedule IA includes, unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, their salts, isomers, and salts of isomers whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1) acetorphine;
(2) acetyldihydrocodeine;
(3) benzylmorphine;
(4) codeine methylbromide;
(5) codeine-n-oxide;
(6) cyprenorphine;
(7) desomorphine;
(8) dihydromorphine;
(9) drotebanol;
(10) etorphine, except hydrochloride salt;
(11) heroin;
(12) hydromorphinol;
(13) methyldesorphine;
(14) methyldihydromorphine;
(15) morphine methylbromide;
(16) morphine methylsulfonate;
(17) morphine-n-oxide;
(18) myrophine;
(19) nicocodeine;
(20) nicomorphine;
(21) normorphine;
(22) pholcodine;
(23) thebacon.
(e) Schedule IA includes, unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, or which contains any of its salts, isomers, whether optical, position, or geometric, or salts of isomers whenever the existence of those salts, isomers, or salts of isomers is possible within the specific chemical designation:
(1) gamma-hydroxybutyric acid (GHB)(some other names include gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate);
(2) when intended or used for human consumption:
(A) gamma butyrolactone (GBL);
(B) 1,4 butanediol (BD);
(C) gamma hydroxyvalerate (GHV);
(D) gamma-valerolactone 4-pentanolide (GVL).
Section: Previous 11.71.100 11.71.110 11.71.120 11.71.140 11.71.150 11.71.160 11.71.170 11.71.180 11.71.190 11.71.195 11.71.200 11.71.210 NextLast modified: November 15, 2016